Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- Check5 days agoChange DetectedAdded the Type 2 diabetes topic and a related topics entry linking to MedlinePlus Genetics. Updated the revision tag from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check13 days agoChange DetectedThe MedlinePlus related topics section no longer lists 'Diabetes Type 2' and 'MedlinePlus Genetics', removing these consumer health resource links from the page.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page's revision was updated from v3.6.3 to v3.6.4, indicating a small internal build update to the page; no study content or data were changed.SummaryDifference0.0%

- Check27 days agoChange DetectedA related topics section has been added featuring Type 2 diabetes and MedlinePlus Genetics. This provides additional background links related to the study without altering its core content.SummaryDifference0.1%

- Check41 days agoChange DetectedA new footer revision tag 'Revision: v3.6.3' was added; several navigation/related items were removed, including 'Type 2 diabetes', 'related topics:', 'MedlinePlus Genetics', and the older 'Revision: v3.6.2'.SummaryDifference0.1%

- Check48 days agoChange DetectedType 2 diabetes was added to the related topics and MedlinePlus Genetics was added as a related topic; the revision tag updated from v3.6.0 to v3.6.2.SummaryDifference0.1%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.